Verco S.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-10-14
Share capital
504,397.60 PLN
Activity description

Verco is a Polish pharmaceutical company specializing in gynecology, ophthalmology, and skin care. It offers advanced pharmaceutical products, including dietary supplements like Pregna PLUS for pregnant women, MUCOVAGIN for intimate area hydration, and TRIVAGIN, a leading oral gynecological probiotic. The company collaborates closely with medical professionals and bases its products on scientific research and evidence-based medicine.

Registered address
Skwer Kard. Stefana Wyszyńskiego 5/6u, 01-015 Warszawa, Poland
Email
Phone
Electronic delivery address
AE:PL-12514-86283-FCICU-29

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$2,082,122

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 77 days late). 5 of 6 audited by a statutory auditor.

  • 202527/06/2026
  • 202418/06/2025
  • 202326/06/2024
  • 202229/06/2023
  • 202130/09/2022
  • 202029/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing1,526 / 24,548
Top 6.2%
City · Warszawa1,285 / 56,729
Top 2.3%
Voivodeship · Mazowieckie1,703 / 76,892
Top 2.2%
Country · Poland5,254 / 297,069
Top 1.8%

Results vs industry

Revenue
This companyUSD 43.58mMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD 7.60mMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 33.60mMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 24.69mMedianUSD 897.46kAverageUSD 31.52m

Offer

Websites

The company has 9 websites. Most of them run on WordPress. The sites are available in: Polish and English. The company measures traffic with Google Analytics and uses the Meta advertising pixel (Facebook, Instagram).

  • verco.com.plPolska firma farmaceutyczna Verco – z myślą o kobietach
    WordPress 3.7Google Tag ManagerYoast SEOPolylangApache
  • afronis.plStrona główna | Afronis
    WordPress 7.1Google Tag ManagerMeta PixelYoast SEOCloudflareApache
  • infectvagin.plStrona główna – InfectVagin
    WordPress 7.1ElementorRank MathApache

Public procurement

The company is the contractor in 3 public sector contracts, worth USD 1.20k in total. They were signed with 3 public buyers.

SubjectAmount
Onco Radiocalm emulsion
$359.94
Medical supplies
$680.08
Purchase of disinfectants
$159.88

Trademarks

The company holds 133 active trademarks registered with the Polish Patent Office. 4 applications are pending. 43 marks have expired or were not registered. The first mark was filed in 2006.

MarkNumberClassesStatusProtected until
Bromfedol (word)Z.5809015Protected Feb 25, 2035
FOMY (word)Z.5809093, 5Protected Feb 25, 2035
Alergeye (word)Z.5742373, 5Protected Sep 20, 2034
Oftalergin (word)Z.5742383, 5Protected Sep 20, 2034
OFTANAC (word)Z.5697315Protected May 17, 2034
MarkProtected until
Bromfedol (word)Feb 25, 2035
FOMY (word)Feb 25, 2035
Alergeye (word)Sep 20, 2034
Oftalergin (word)Sep 20, 2034
OFTANAC (word)May 17, 2034

Job offers

The company has its own careers page: verco.com.pl.

Authorized Representatives

Agnieszka Anna Zaremska age 54 – Attorney-in-fact (joint)
Agnieszka Hanna Miller age 57 – Management Board Member
Anna Martyna age 56 – Attorney-in-fact (sole)
Marcin Marek Czeladzki age 52 – Management Board Member
Karol Szczepan Korda age 47 – Management Board Member

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company independently. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board together with a commercial proxy is required to make declarations on behalf of the company.

Supervisory board

Agnieszka Barbara Bukowińska-Zawadka age 62 – Supervisory Board Member
Rafał Mania age 56 – Supervisory Board Member
Włodzimierz Tomasz Zawadka age 64 – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
Ofta sp. z o.o.
100%
Ofta Pharma sp. z o.o.
100%
Pharma4vet sp. z o.o.
100%

Bank accounts

Registered as a VAT taxpayer on 2006-11-06.

  • mBank
    25 1140 1010 0000 5154 3700 1013
  • mBank
    90 1140 1010 0000 5154 3700 1007
  • mBank
    47 1140 1010 0000 5154 3700 1005

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 150.5K

MSiG notices

9 notices recorded in the Court and Commercial Gazette (MSiG).

Publication dateEvent
Dec 9, 2025Financial statement published
Aug 19, 2024Financial statement published
Nov 4, 2020Commercial Companies Code notice
Oct 7, 2020Commercial Companies Code notice
Sep 22, 2020Commercial Companies Code notice

Public aid

4 public aid cases recorded, with a total value of $953,269.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Synoptis Pharma sp. z o.o.
Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H. Branch (foreign co.)
Wörwag Pharma Operations sp. z o.o.
DAX Cosmetics sp. z o.o.
Exim Pharma sp. z o.o.
Aristo Pharma sp. z o.o.
Przedsiębiorstwo Farmaceutyczne Farmapol sp. z o.o.
Silesian Pharma sp. z o.o.
Vitamed Pharmaceuticals sp. z o.o.
Wellmedica sp. z o.o.

Change history

DateEvent
2025-02-07Switch to PKD 2025
2024-10-03Share capital increase
2024-09-12Share capital reduction
2022-10-14Share capital increase
2022-07-22Share capital reduction

FAQ

Last updated: 2026-08-24